Peptide Supply Chain Educational Guide
An unvarnished reference covering compounding pharmacy distinctions (503A vs 503B), regulatory compliance frameworks, USP <797>/<795> cleanroom standards, and 3rd-party batch quality testing.
Testing & Quality Assurance
Every raw Active Pharmaceutical Ingredient (API) batch — including Semaglutide, Tirzepatide, BPC-157, and NAD+ — must undergo analytical testing by independent, accredited laboratories before distribution.
High-Performance Liquid Chromatography and Liquid Chromatography-Mass Spectrometry establish exact compound purity percentages and impurity profiles.
Sterility testing ensures absence of bacterial endotoxins, heavy metals, and residual solvent contaminants according to USP standards.
Ready to explore verified supply chain data?
Get instant access to audited compounding pharmacy records, cGMP API suppliers, and custom order routing tools.